The Result of Neuman Systems Model Application on the Infection control among mothers of Children with Leukemia Receiving Chemotherapy
Article Sidebar
Main Article Content
Abstract
Purpose: To compare infection control among mothers of children with leukemia receiving chemotherapy between the group that applied the Neuman systems model and another group that using conventional nursing care
Research design: Quasi-experimental research
Methods: The thirty mothers of children with leukemia receiving chemotherapy in Ramathibodi hospital are the subject selected by purposive sampling. The subjects were assigned to the experimental group and control group equally 15 subjects in each group. The mother in the experimental group receives the nursing care that applied the Neuman systems model. Data were collected by the infection prevention behaviors questionnaire. Data were analyzed by descriptive statistics and the Mann-Whitney U test.
Result: The mother of children with leukemia receiving chemotherapy who receiving nursing care that applied the Neuman systems model performed better at infection control that was the one part of infection prevention behaviors, at a statistical level of .05.
Conclusion: The result of this study shows that nursing care that applied the Neuman systems model was able to enable mothers to prevent infection in children with leukemia receiving chemotherapy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์ของบทความที่ตีพิมพ์เป็นของวารสารพยาบาลศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย ทั้งฉบับตีพิมพ์เป็นรูปเล่มและเอกสารออนไลน์
References
Wiangnon S, Veerakul G, Nuchprayoon I,
Seksarn P, Hongeng S, Krutvecho T,
et al. Childhood cancer incidence and
survival 2003-2005, Thailand: study
from the Thai Pediatric Oncology Group.
Asian Pac J Cancer Prev 2011; 12(9):
-20.
Veerakul K, Sanpakit K. Child Cancer. Bangkok:
Chaunpim; 2002.
Wanitpongpun C, Amampai W, Teawtrakul N,
Chansung K, Sirijeerachai C. Clinical
characteristics, causative organisms, role
of serum galactomannan and treatment
outcomes of acute leukemia patients
with febrile neutropenia. Srinagarind
Med J 2017; 32(6): 511-8. (in Thai)
Lekdamrongkul P, Pongthavornkamol K,
Chewapoonpon C, Siritanaratkul N.
Factors associated with febrile
neutropenia in acute leukemic patients
receiving chemotherapy. J Nurs Sci
; 27(2): 58-68. (in Thai)
Perkins JL, Harris A, Pozos TC. Immune
dysfunction after completion of
childhood leukemia therapy. Pediatr
Hematol Oncol J 2017; 39(1): 1-5.
Chong CY, Tan AM, Lou J. Infections in acute
lymphoblastic leukaemia. Ann Acad
Med Singapore 1998; 27: 491-5.
Pizzo PA. Management of fever in patients
with cancer and treatment-induced
neutropenia. N Engl J Med 1993;
(18): 1323-32.
Neuman BM, Fawcett J. The neuman systems
model. 4th ed. Upper Saddle River, NJ:
Prentice Hall; 2002.
Maxwell C, Stein A. Implementing evidencebased
guidelines for preventing
chemotherapy-induced neutropenia:
From paper to clinical practice.
Community Oncol 2006; 8(3): 530-6.
Doi: 10.1016/S1548-5315(11)70747-1.
Worapanwisit T, Paritsiraprapa C, Rotchanarak
W. Prevention of febrile neutropenia in
acute leukemia patients: Role of nurse.
JRTAN 2020; 21(3): 11-9.